Approval · Notice of Compliance 17397 · 2015
LIPIDIL MICRO: Notice of Compliance 17397
Issued October 19, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17397
- Date
- October 19, 2015
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIPIDIL MICRO | 02146959 | Cancelled Post Market |
| LIPIDIL SUPRA | 02241602 | Marketed |
Medicinal ingredients
- FENOFIBRATE 200 MG per CAP
- FENOFIBRATE 160 MG per TAB